# Evommune, Inc.: Form 8-K, filed Jul 30, 2026

- Company: [Evommune, Inc.](/companies/evmn.md) (CIK 2044725)
- Form: 8-K
- Filed: 2026-07-30
- Accepted by EDGAR: Jul 30, 2026, 08:01 ET
- Period: 2026-07-29
- Accession: 0001193125-26-324972
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2044725/000119312526324972/evmn-20260731.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2044725/000119312526324972/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2044725/000119312526324972/evmn-20260731.htm

Filed Jul 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-324972. Last ingested by Listed: Nov 5, 2026, 11:36 ET. No prices; not investment advice.